Barclays PLC Has $20.36 Million Position in Revvity, Inc. (NYSE:RVTY)

Barclays PLC lowered its stake in Revvity, Inc. (NYSE:RVTY - Free Report) by 3.8% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 182,448 shares of the company's stock after selling 7,115 shares during the quarter. Barclays PLC owned approximately 0.15% of Revvity worth $20,362,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also bought and sold shares of RVTY. Victory Capital Management Inc. boosted its holdings in shares of Revvity by 17.4% in the 4th quarter. Victory Capital Management Inc. now owns 70,250 shares of the company's stock valued at $7,841,000 after buying an additional 10,390 shares during the last quarter. JPMorgan Chase & Co. lifted its stake in Revvity by 13.7% in the third quarter. JPMorgan Chase & Co. now owns 344,115 shares of the company's stock valued at $43,961,000 after acquiring an additional 41,497 shares during the last quarter. Contravisory Investment Management Inc. lifted its position in shares of Revvity by 1,715.9% in the fourth quarter. Contravisory Investment Management Inc. now owns 69,186 shares of the company's stock valued at $7,722,000 after buying an additional 65,376 shares during the last quarter. Janney Montgomery Scott LLC boosted its stake in shares of Revvity by 87.0% during the 4th quarter. Janney Montgomery Scott LLC now owns 7,891 shares of the company's stock worth $881,000 after acquiring an additional 3,672 shares during the period. Finally, Mirae Asset Global Investments Co. Ltd. increased its holdings in shares of Revvity by 41.5% during the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 12,072 shares of the company's stock worth $1,352,000 after acquiring an additional 3,542 shares during the last quarter. Institutional investors own 86.65% of the company's stock.

Analysts Set New Price Targets

RVTY has been the subject of several research reports. Sanford C. Bernstein cut shares of Revvity from an "outperform" rating to a "market perform" rating and set a $130.00 price objective for the company. in a research report on Friday, January 10th. Robert W. Baird reduced their target price on shares of Revvity from $141.00 to $127.00 and set an "outperform" rating for the company in a report on Monday. Barclays reduced their target price on shares of Revvity from $140.00 to $110.00 and set an "overweight" rating for the company in a research report on Thursday, April 10th. Raymond James reaffirmed an "outperform" rating and set a $145.00 price target (up from $140.00) on shares of Revvity in a research report on Monday, February 3rd. Finally, Wells Fargo & Company cut their price objective on shares of Revvity from $130.00 to $102.00 and set an "equal weight" rating for the company in a report on Thursday, April 17th. Four investment analysts have rated the stock with a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average target price of $130.50.

Insider Activity at Revvity

In other news, insider Joel S. Goldberg sold 15,170 shares of the company's stock in a transaction on Thursday, January 30th. The shares were sold at an average price of $126.73, for a total transaction of $1,922,494.10. Following the completion of the transaction, the insider now directly owns 33,400 shares in the company, valued at approximately $4,232,782. This represents a 31.23 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. 0.68% of the stock is owned by insiders.

Revvity Price Performance

RVTY traded up $1.40 during trading on Wednesday, hitting $93.73. 1,702,960 shares of the stock traded hands, compared to its average volume of 904,111. The business has a 50 day moving average price of $105.93 and a 200 day moving average price of $113.61. The company has a market cap of $11.26 billion, a price-to-earnings ratio of 42.41, a PEG ratio of 3.82 and a beta of 1.07. Revvity, Inc. has a twelve month low of $88.53 and a twelve month high of $129.50. The company has a debt-to-equity ratio of 0.41, a current ratio of 3.60 and a quick ratio of 3.03.

Revvity (NYSE:RVTY - Get Free Report) last announced its quarterly earnings data on Friday, January 31st. The company reported $1.42 earnings per share for the quarter, topping the consensus estimate of $1.37 by $0.05. Revvity had a return on equity of 7.68% and a net margin of 9.81%. During the same quarter in the prior year, the company posted $1.25 earnings per share. Equities research analysts forecast that Revvity, Inc. will post 4.94 earnings per share for the current fiscal year.

Revvity Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, May 9th. Investors of record on Friday, April 18th will be given a dividend of $0.07 per share. This represents a $0.28 dividend on an annualized basis and a yield of 0.30%. The ex-dividend date is Thursday, April 17th. Revvity's dividend payout ratio is 12.67%.

About Revvity

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.